<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-pharmaceuticals-13-00313">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Krawitz</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mraheil</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Stein</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Imirzalioglu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Domann</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pleschka</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hain</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses</article-title>
  <source>BMC Complement. Altern. Med.</source>
  <year>2011</year>
  <volume>11</volume>
  <elocation-id>16</elocation-id>
  <pub-id pub-id-type="doi">10.1186/1472-6882-11-16</pub-id>
  <?supplied-pmid 21352539?>
  <pub-id pub-id-type="pmid">21352539</pub-id>
 </element-citation>
</ref>
